Fig. 2
From: Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
Immune cell marker expression in squamous differentiated bladder cancer (Sq-BLCA). A Immunohistochemical stainings of CD8, CD79A, CD163 and CD56 are shown for representative tissue cores and intratumoural (iTILs) and stromal tumour-infiltrating lymphocytes (sTILs), respectively. Tumour and stromal components are histologically represented by H&E staining. Black scale bar: 50 µM (iTILs CD79A and CD56); 100 µm (CD8, CD163, sTILs CD56); 250 µm (sTILs CD79A). (B-E) Graphs display distribution of immune cell marker expression of CD8 (B), CD79A (C), CD163 (D) and CD56 (E) in iTILs (red bars) and sTILs (green bars)